Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-24

Clinical Trial Update: Efficacy of Insulin Lispro Mix 50/50 Therapy [NA]

View source ↗

Summary

This clinical trial update discusses the efficacy of insulin lispro mix 50/50 therapy for type 2 diabetes mellitus, with the current status reported as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog Mix50/50 (insulin lispro mix 50/50)

Snippet

Sponsor: Aichi Gakuin University | Conditions: Diabetes Mellitus, Type 2 | NA | Status: UNKNOWN